سعر سيفيروم 2 جم فيال وريد 2022

Cefpirome 2 gm vial i.v.: Cefpirome (Kahira > eva pharma).

• Parenteral fourth-generation cephalosporin for severe susceptible infections (e.g. complicated UTI, pneumonia, skin/soft tissue, bacteremia) as historically labeled internationally; no current US DailyMed SPL found in this pass (ingredient-level / manufacturer directory notes).Population: AdultsPubChem, WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Hypersensitivity to cefpirome or other cephalosporins/beta-lactams.General active-ingredient information · PubChem, WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Cross-hypersensitivity with beta-lactams; C. difficile–associated diarrhea; dose adjust in renal impairment (ingredient-level).General active-ingredient information · PubChem, WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• AminoglycosidesPossible additive nephrotoxicity; monitor renal function.PubChem, WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Use in pregnancy only if clearly needed; limited data (ingredient-level).General active-ingredient information · PubChem, WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)
• Unknown extent of excretion in human milk; use caution (ingredient-level).General active-ingredient information · PubChem, WHO Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index)

• Cefpirome: Parenteral fourth-generation cephalosporin; bactericidal beta-lactam inhibiting bacterial cell-wall synthesis.